Generics Access Project

Advocating for policies that promote generic competition and
efficient approval of generic medicines.

[Generics Access Project @GenericsProject]

Generic drugs are a critical part of the U.S. health care system. But how well do patients understand them? GAP’s national survey found knowledge gaps and mixed trust in generics’ safety, effectiveness, and manufacturing.

📊 Explore the results: https://t.co/5rprWWgqC4

[Generics Access Project @GenericsProject]

Drug shortages can have serious consequences for patients, including:

▪️ Delayed or disrupted care
▪️ Increased costs
▪️ Unexpected side effects when using alternative treatments

Learn more: https://t.co/jEc33Xy1q8

[Generics Access Project @GenericsProject]

Today, GAP spotlights another steering committee member: Patients Rising.

@patientsrising trains patients and caregivers to bring their real struggles into Congress, state legislatures, and regulatory agencies — and turn them into policy.

Learn more: https://t.co/0YcbgRu4oI

[Generics Access Project @GenericsProject]

‼️STARTING NOW‼️

Tune into GAP's webinar, “Engaging FDA's User Fee Process" now, to hear from experts about getting involved in the FDA user fee reauthorization process to ensure timely patient access to prescription and generic medicines.

🔗 Join NOW: https://t.co/jSIf47uBRv

[Generics Access Project @GenericsProject]

Join GAP and @patientaccess' webinar, "Engaging in FDA's User Fee Process" on September 21 to learn how patient advocates can get involved in the FDA user fee reauthorization process to ensure patient access to generic medicines.

‼️ Register now‼️ https://t.co/viDRLLOmFF

[Generics Access Project @GenericsProject]

📢 Upcoming Webinar: Engaging in the FDA’s User Fee Process

The upcoming GDUFA reauthorization offers advocates an important opportunity to help shape the FDA’s user fee programs.

Register to learn about the process and how to make your voice heard: https://t.co/jSIf47uBRv

[Generics Access Project @GenericsProject]

The Generic Drug User Fee Amendments help the @FDA expand access to effective and affordable generic medicines. With GDUFA IV’s 2027 renewal approaching, organizations can advocate for continued patient access.

Learn more about how to get involved today: https://t.co/aJdrHYmMz4

[Generics Access Project @GenericsProject]

The Generics Access Project advocates for policies that promote #generic competition and efficient approval of generic medicines.

Visit GAP’s website to learn more: https://t.co/wGu9UD1MFG

[Generics Access Project @GenericsProject]

GAP’s survey found that patients overwhelmingly recognize the value #generics bring to patients and the health care system.

Read the survey report: https://t.co/5rprWWgqC4

[Generics Access Project @GenericsProject]

This week's GAP steering committee spotlight is the Global Colon Cancer Association. Their mission is to advocate for equitable access to quality colorectal cancer screenings, testing, treatments, and care.

Learn more about @GlobalCRC: https://t.co/YTPcbJxS8b

[Generics Access Project @GenericsProject]

The Generics Access Project has 4 main priorities, all aimed at advocating for policies that promote generic competition and efficient approval of generic medicines.

Learn more: https://t.co/p82THyX2qz

[Generics Access Project @GenericsProject]

Generic drugs are a critical part of the US health care system. But even as patients readily take generic medications, what is their level of trust in generics’ efficacy, safety and manufacturing?

Read GAP's survey report to find out: https://t.co/5rprWWgqC4

[Generics Access Project @GenericsProject]

#DYK? Skinny labeling is a process that allows generic drug manufacturers to seek FDA approval for uses of a drug no longer protected by patents. This approach offers patients lower drug prices.

Learn more through GAP's one-pager resource: https://t.co/AmeQ5gq05D

[Generics Access Project @GenericsProject]

GAP's next member spotlight is the International Cancer Advocacy Network.

ICAN helps late-stage cancer patients access information about drug options, clinical trials, personalized treatment, and physician referrals.

Learn more about @WarOnCancer: https://t.co/dMWOGD0NhA

[Generics Access Project @GenericsProject]

Another valued steering committee member for GAP is the Global Allergy & Airways Patient Platform.

@gaapporg empowers patients with allergies, airways, and
atopic disease around the world.

Learn more:https://t.co/KNPnDYewx1

[Generics Access Project @GenericsProject]

Affordable access to medicines depends heavily on the availability of generics. That is why the Generics Access Project encourages policy changes that foster generic competition and efficient approvals.

Learn more about GAP's priorities and mission today:
https://t.co/wGu9UD1MFG

[Generics Access Project @GenericsProject]

Generic medicines do not reach patients by chance; they depend on a review process by the FDA. User fee programs play a vital role in this review process, ensuring increased patient access to generic medicines.

Learn more in GAP's new video: https://t.co/mBT9SowUjI

[Generics Access Project @GenericsProject]

Next up for GAP's steering committee spotlights is the Foundation for Sarcoidosis Research.

@StopSarcoidosis is the leading organization dedicated to finding a cure for sarcoidosis and improving patient care.

Learn more about FSR: https://t.co/fSfhniIUHN

[Generics Access Project @GenericsProject]

This week's GAP steering committee spotlight is the Color of Crohn's & Chronic Illness. Their mission is to improve the quality of life for BIPOC who are affected by IBD, digestive disorders & associated chronic illnesses. Learn more about @colorofgi: https://t.co/viMgU2gjtk

[Generics Access Project @GenericsProject]

Over the next few weeks, GAP will be reintroducing members of its steering committee individually.

These member organizations comprise the Generics Access Project and work together to drive our mission of improving patient access to affordable #generic drugs.

Stay tuned!